Sreenivas S Bhat

Title: Sreenivas S Bhat: Innovator in Pharmaceutical Compositions

Introduction

Sreenivas S Bhat is a notable inventor based in Kendall Park, NJ (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 11 patents. His work focuses on innovative pharmaceutical compositions that have the potential to improve therapeutic outcomes.

Latest Patents

One of his latest patents involves pharmaceutical compositions comprising (S)-2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione. This patent outlines methods of using these compositions, which include oral dosage formulations. The compositions may consist of the compound itself, its enantiomers, mixtures of enantiomers, tautomers, isotopologs, or pharmaceutically acceptable salts, along with a suitable carrier or diluent.

Career Highlights

Sreenivas has worked with prominent companies in the pharmaceutical industry, including Celgene Corporation and Signal Pharmaceuticals, Inc. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.

Collaborations

Throughout his career, Sreenivas has collaborated with talented professionals, including Darshan Parikh and Scott Burnside. These collaborations have likely enhanced his research and development efforts in the pharmaceutical field.

Conclusion

Sreenivas S Bhat is a distinguished inventor whose work in pharmaceutical compositions has the potential to make a significant impact in medicine. His innovative approaches and collaborations reflect his commitment to advancing healthcare solutions.